RBC Capital Markets adjusted their outlook on Morgan Stanley (NYSE:MS) shares, raising the price target from $122.00 to $142.00. The firm maintained a Sector Perform rating on the stock. The upgrade comes as Morgan Stanley's stock trades near its 52-week high of $136.

Bank stocks have been on a post-election upswing, with the KBW Nasdaq Bank Index ( ^BKX) up 14% since Trump won the presidency. Morgan Stanley has notched a 17% gain. Investors have a dinner plate to choose from to explain the bullishness.

RBC Capital analyst Arun Viswanathan maintained a Buy rating on Ball (BALL – Research Report) yesterday and set a price target of $75.00. The

Morgan Stanley's profit more than doubled in the fourth quarter, fueled by a wave of dealmaking and stock sales that drove its revenue to a full-year record.

RBC Capital Markets analyst Maurice Choy identifies relative “safer havens” in the yield-heavy energy infrastructure sector, National Bank economist Warren Lovely noted the important fact that global interest in Canadian bonds remains high,

“We think Morgan Stanley benefits from favorable secular trends in the capital markets, wealth management, and investment banking,” he said in a research note. Morgan Stanley’s revenue from ...

Brief anchors Seana Smith and Brad Smith examine the key market developments driving Monday's trading session. Major banks will launch first-quarter earnings season this week, with reports from Citigroup (C),

In a report released today, James Edwardes Jones from RBC Capital maintained a Buy rating on Reckitt (RKT – Research Report), with a price

RBC Capital analyst Kenneth Herbert maintained a Buy rating on Boeing (BA – Research Report) today and set a price target of $200.00. The

RBC Capital analyst Arun Viswanathan maintained a Hold rating on Sealed Air (SEE – Research Report) yesterday and set a price target of $38.00.

Citi (C), JPMorgan Chase (JPM), Goldman Sachs (GS), and Wells Fargo (WFC) report on Wednesday, while Bank of America (BAC) and Morgan Stanley (MS) release results on Thursday. RBC Capital markets ...

Dyne Therapeutics Inc (DYN) stock saw a modest uptick, ending the day at $14.55 which represents a slight increase of $0.42 or 2.97% from the prior close of $14.13. The stock opened at $14.3 and touched a low of $13.